Skip to main content
. 2021 Apr 8;6(6):1732–1737. doi: 10.1016/j.ekir.2021.03.897

Figure 2.

Figure 2

(a) Evolution of the biochemical parameters (i.e., platelets, lactate dehydrogenase [LDH], hemoglobin [Hb], and schistocytes) after admission and during therapies (i.e., therapeutic plasma exchange [TPE], hemodialysis, methylprednisolone, and initiation of eculizumab). (b) The trend of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgG antibodies during TPE.